LIXT Average Annual Return 10 Years
LIXT Average Annual Return Chart 10 Years
Growth of $10,000.00
Without Dividends Reinvested Into LIXT

Also see:
• LIXT stock yearly return 2016
• LIXT stock yearly return 2017
• LIXT stock yearly return 2018
• LIXT stock yearly return 2019
• LIXT stock yearly return 2020
• LIXT stock yearly return 2021
• LIXT stock yearly return 2022
• LIXT stock yearly return 2023
• LIXT stock yearly return 2024
• LIXT stock yearly return 2025
• LIXT YTD return
Average Annual Return Benchmarks
Compare LIXT average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
LIXT Share Performance
LIXT Average Annual Return Table 10 Years
Start date: 04/19/2016
End date: 04/17/2026
Start price/share: $8.40
End price/share: $3.61
Dividends collected/share: $0.00
Total return: -57.02%
LIXT Average Annual Return: -8.10%
Starting investment: $10,000.00
Ending investment: $4,296.90
Years: 10.00


LIXT average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology Holdings, Inc. is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. Co.'s product pipeline is primarily focused on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers. Co. encompasses that inhibitors of protein phosphatases have broad therapeutic potential not only for cancer but also for other debilitating and life-threatening diseases. It is focused on development activities of its LB-100 series of drugs. The LIXT average annual return 10 years is shown above.

The Average Annual Return on the LIXT average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether LIXT average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the LIXT average annual return calculation with any dividends reinvested as applicable (on ex-dates).
LIXT Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree LIXT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!
Average Annual Return Peers
Lixte Biotechnology Holdings (LIXT) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

LLY Average Annual Return
LMAT Average Annual Return
LMNX Average Annual Return
LNSR Average Annual Return
LNTH Average Annual Return
LONA Average Annual Return
LPCN Average Annual Return
LQDA Average Annual Return
LRMR Average Annual Return
LSTA Average Annual Return
More Healthcare companies »
What has the average annual return been for LIXT over the past ten years?
✔️Accepted answer: The ten year LIXT average annual return has been -8.10%.

What start date was used in your LIXT average annual return calculation?
✔️Accepted answer: The start date was 04/19/2016.

What end date was used in your LIXT average annual return calculation?
✔️Accepted answer: The end date was 04/17/2026.

If I had invested $10,000 into LIXT ten years ago, how much would I have today?
✔️Accepted answer: Today, as of 04/17/2026, you would have $4,296.90.

What does that work out to on a total return basis?
✔️Accepted answer: The LIXT ten year total return ending 04/17/2026 works out to -57.02%.


Also see:
• LIXT stock yearly return 2016
• LIXT stock yearly return 2017
• LIXT stock yearly return 2018
• LIXT stock yearly return 2019
• LIXT stock yearly return 2020
• LIXT stock yearly return 2021
• LIXT stock yearly return 2022
• LIXT stock yearly return 2023
• LIXT stock yearly return 2024
• LIXT stock yearly return 2025
• LIXT YTD return
 

LIXT Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2026, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.